Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;149(7):1784-93.
doi: 10.1053/j.gastro.2015.08.011. Epub 2015 Aug 20.

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

Affiliations

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

Rohit Loomba et al. Gastroenterology. 2015 Dec.

Abstract

Background & aims: Little is known about the heritability of hepatic fibrosis, and the heritability of hepatic steatosis has not been assessed systematically in adults. We investigated the heritability of hepatic fibrosis and steatosis in a community-dwelling twin cohort.

Methods: We performed a cross-sectional analysis of a cohort of well-characterized twins residing in Southern California including 60 pairs of twins (42 monozygotic and 18 dizygotic; average age, 45.7 ± 22.1 y; average body mass index, 26.4 ± 5.7 kg/m(2)). We collected data on medical history, physical examinations, fasting laboratory test results, and liver health; all participants underwent an advanced magnetic resonance imaging (MRI) examination of the liver from January 2012 through January 2015. Hepatic steatosis was quantified noninvasively by MRI and determined based on the proton-density fat fraction (MRI-PDFF); liver fibrosis was measured based on stiffness measured by magnetic resonance elastography.

Results: Twenty-six of the 120 subjects (21.7%) had nonalcoholic fatty liver disease (defined as MRI-PDFF ≥ 5% after exclusion of other causes of hepatic steatosis). The presence of hepatic steatosis correlated between monozygotic twins (r(2) = 0.70; P < .0001) but not between dizygotic twins (r(2) = 0.36; P = .2). The level of liver fibrosis also correlated between monozygotic twins (r(2) = 0.48; P < .002) but not between dizygotic twins (r(2) = 0.12; P = .7). In multivariable models adjusted for age, sex, and ethnicity, the heritability of hepatic steatosis (based on MRI-PDFF) was 0.52 (95% confidence interval, 0.31-0.73; P < 1.1 × 10(-11)) and the heritability of hepatic fibrosis (based on liver stiffness) was 0.5 (95% confidence interval, 0.28-0.72; P <6.1 × 10(-11)).

Conclusions: A study of twins provides evidence that hepatic steatosis and hepatic fibrosis are heritable traits.

Keywords: Fatty Liver; Genetic Factors; NAFLD; NASH.

PubMed Disclaimer

Conflict of interest statement

Potential competing interests: none

All authors report that no conflicts of interest exist.

Figures

Figure 1
Figure 1. Twin-ship correlation by hepatic steatosis assessed by MRI
The mono-zygotic twin-pairs showed a robust correlation in hepatic steatosis as quantified by MRI-PDFF (r2 of 0.70, p-value <0.0001) but not the di-zygotic twin-pairs (r2 of 0.36, p-value .2); demonstrating that hepatic steatosis is a heritable trait.
Figure 2
Figure 2. Twin-ship correlation by hepatic fibrosis assessed by MRE
The mono-zygotic twin-pairs showed a robust correlation in liver fibrosis as quantified by MRE-stiffness (r2 of 0.48, p-value <0.002) but not the di-zygotic twin-pairs (r2 of .12, p-value .7); demonstrating that hepatic fibrosis is a heritable trait.
Figure 3
Figure 3. Novel MRI-PDFF map and MRE-map demonstrating the detailed phenotyping of the twins based upon the presence (or absence) of hepatic steatosis
Footnote: A twin-pair that is concordant for presence of NAFLD and advanced fibrosis (figure 3A), a twin-pair that is concordant for the absence of NAFLD (figure 3B), and a twin-pair that is discordant for NAFLD (figure 3C)
Figure 3
Figure 3. Novel MRI-PDFF map and MRE-map demonstrating the detailed phenotyping of the twins based upon the presence (or absence) of hepatic steatosis
Footnote: A twin-pair that is concordant for presence of NAFLD and advanced fibrosis (figure 3A), a twin-pair that is concordant for the absence of NAFLD (figure 3B), and a twin-pair that is discordant for NAFLD (figure 3C)
Figure 3
Figure 3. Novel MRI-PDFF map and MRE-map demonstrating the detailed phenotyping of the twins based upon the presence (or absence) of hepatic steatosis
Footnote: A twin-pair that is concordant for presence of NAFLD and advanced fibrosis (figure 3A), a twin-pair that is concordant for the absence of NAFLD (figure 3B), and a twin-pair that is discordant for NAFLD (figure 3C)

References

    1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592–609. - PubMed
    1. Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372–84. - PubMed
    1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686–90. - PubMed
    1. Williamson RM, Price JF, Glancy S, et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2011;34:1139–44. - PMC - PubMed
    1. Singh S, Allen AM, Wang Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643–54. e1–9. quiz e39–40. - PMC - PubMed

Publication types

MeSH terms